Epsilon protein kinase C as a potential therapeutic target for the ischemic heart

Cardiovascular Research
Koichi InagakiDaria Mochly-Rosen

Abstract

Ischemic heart disease is the leading cause of morbidity and mortality in the western world. Ischemic damage can occur by acute myocardial infarction, stable angina, cardiac stunning, and myocardial hibernation. In addition, 'scheduled' ischemic events, occurring during cardiac surgery, heart transplantation, and elective angioplasty, can also result in cardiac damage. Ischemic or pharmacological preconditioning can decrease the extent of damage to the myocardium. Although the mechanism of preconditioning-mediated cardioprotection is not fully understood, epsilonPKC has been implicated as a critical mediator of this process in animal studies. The use of isozyme-specific pharmacological tools has permitted a better elucidation of the upstream stimuli and the downstream transducers of epsilonPKC in the pathways leading to cardioprotection. While little is known about the role of epsilonPKC in these pathways in humans, animal studies suggest a potential therapeutic role of epsilonPKC. This review will focus on the role of epsilonPKC in cardiac protection and on the signal transduction cascades that have been implicated in this protection.

Citations

Mar 26, 2013·Pflügers Archiv : European journal of physiology·Donna H Korzick, Timothy S Lancaster
May 28, 2010·Cardiovascular Drugs and Therapy·Xiulan YangJames M Downey
Jun 2, 2007·Heart Failure Reviews·Derek J Hausenloy, Derek M Yellon
May 23, 2007·Heart Failure Reviews·Elissavet KardamiPeter A Cattini
Jun 19, 2010·Journal of Cardiovascular Translational Research·Shigeki MiyamotoJoan Heller Brown
May 22, 2013·Cell Research·Jin-Min GuoDing-Feng Su
Dec 1, 2012·Nature Reviews. Drug Discovery·Daria Mochly-RosenKevin V Grimes
Sep 15, 2007·The New England Journal of Medicine·Derek M Yellon, Derek J Hausenloy
Jan 22, 2010·Molecular Biology of the Cell·Iryna O ZubovychMichael G Roth
Oct 9, 2007·Annual Review of Pharmacology and Toxicology·Eric ChurchillDaria Mochly-Rosen
Feb 8, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Juan Carlos RoblesCristine L Heaps
Sep 2, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·T S LancasterD H Korzick
Jan 7, 2009·Therapeutic Advances in Cardiovascular Disease·Eric N ChurchillDaria Mochly-Rosen
Jan 21, 2014·Psychopharmacology·Fernanda ArmaniJosé Carlos Fernandes Galduróz
Jul 10, 2013·Future Cardiology·Matthew J Brooks, David T Andrews
Nov 26, 2013·Journal of Molecular and Cellular Cardiology·Jing HuangVictor J Dzau
Apr 20, 2014·The Journal of Surgical Research·Guo-Qiang ZhongFei Xiao
Aug 4, 2011·Journal of Molecular and Cellular Cardiology·Nicolas DuquesnesBertrand Crozatier
Mar 3, 2009·Journal of Molecular and Cellular Cardiology·Vivek SivaramanDerek M Yellon
Jan 16, 2008·Advances in Enzyme Regulation·Per-Olof Berggren, Christopher J Barker
Aug 15, 2008·Drug Discovery Today. Disease Mechanisms·Eric R Gross, Garrett J Gross
Aug 4, 2007·Biochemical and Biophysical Research Communications·Wei-Hua ZhangChang-Qing Xu
Feb 18, 2009·Journal of Cellular and Molecular Medicine·Sanjeev GuptaBertrand Joseph
Feb 18, 2011·British Journal of Pharmacology·Offir ErtrachtOfer Binah
Jul 28, 2007·Journal of Molecular and Cellular Cardiology·Tomoyoshi KoyanagiDaria Mochly-Rosen
Apr 5, 2016·Biochimica Et Biophysica Acta·Stephen C Kolwicz
May 16, 2013·Cellular Signalling·Phillip C MoschellaDhandapani Kuppuswamy
Apr 16, 2014·Biochimica Et Biophysica Acta·Antonio L Egea-JiménezJuan C Gómez-Fernández
May 11, 2013·Peptides·Ali Mohammad Alizadeh, Parasto Mirzabeglo
Oct 15, 2014·Trends in Pharmacological Sciences·Mathias Rask-AndersenHelgi B Schiöth
Jul 25, 2013·Journal of Molecular and Cellular Cardiology·Martina MontiMarina Ziche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.